Literature DB >> 12081739

Retrospective study of acute toxicity following short-course preoperative radiotherapy.

A Hartley1, S Giridharan, L Gray, L Billingham, T Ismail, J I Geh.   

Abstract

BACKGROUND: The use of short-course preoperative radiotherapy (25 Gy in five fractions over 1 week) in resectable rectal cancer reduces local recurrence but is associated with an increased risk of postoperative complications and late toxicity. This study aimed to identify those patients who are unlikely to benefit from short-course preoperative radiotherapy and the factors associated with acute toxicity.
METHODS: All patients who received short-course preoperative radiotherapy at a university hospital in 1998 and 1999 were included in this retrospective study. The association between complications occurring within 3 months and patient demographics, radiotherapy technique, surgical details and overall treatment time (OTT) was assessed by univariate and multivariate analysis.
RESULTS: The mortality rate at 30 days was 6 per cent in the 177 patients identified. Thirty-seven per cent of patients had either Dukes' A tumours, surgically incurable disease or positive circumferential margins. One or more complications occurred in 38 per cent of patients. On multivariate analysis an OTT of more than 13 days (P = 0.03), age (P = 0.02) and length of the radiotherapy field (P = 0.05) were associated with an increased risk of complications.
CONCLUSION: Surgery within 1 week of completing short-course preoperative radiotherapy improved preoperative staging and use of an optimal radiotherapy technique will result in fewer patients at risk of acute toxicity.

Entities:  

Mesh:

Year:  2002        PMID: 12081739     DOI: 10.1046/j.1365-2168.2002.02136.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Pre-operative radiotherapy to improve local control and survival in rectal cancer optimal time intervals between radiation and surgery.

Authors:  Antonio Cassio Assis Pellizzon
Journal:  Rep Pract Oncol Radiother       Date:  2018-10-10

2.  Feasibility of adequate resectable rectal cancer treatment in a third-level hospital.

Authors:  J Gallego-Plazas; F Menárguez-Pina; A Maestre-Peiró; V González-Orozco; F Andreu; M J Escudero-Barea; M A Morcillo
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

3.  Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.

Authors:  Duck Hyoun Jeong; Han Beom Lee; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Nam Kyu Kim
Journal:  J Korean Surg Soc       Date:  2013-05-28

4.  Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery.

Authors:  A A F A Veenhof; R H J Kropman; A F Engel; M E Craanen; S Meijer; O W M Meijer; D L van der Peet; M A Cuesta
Journal:  Int J Colorectal Dis       Date:  2006-09-29       Impact factor: 2.796

Review 5.  Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?

Authors:  Bengt Glimelius
Journal:  Front Oncol       Date:  2014-04-07       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.